Reaction
Porphyria Non-Acute reporting signals
As of the last recalculation, Porphyria Non-Acute appears in 434 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is RIBAVIRIN (PRR 60.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ribavirin | 68 | 60.0 | 60.0 |
| Tenofovir Disoproxil Fumarate Tablets | 10 | 56.8 | 56.9 |
| Lopinavir And Ritonavir | 14 | 51.2 | 51.2 |
| Nevirapine | 7 | 37.8 | 37.8 |
| Efavirenz | 8 | 35.0 | 35.1 |
| Iron Sucrose | 6 | 30.6 | 30.6 |
| Peginterferon Alfa-2A | 30 | 28.5 | 28.5 |
| Sofosbuvir | 10 | 24.9 | 24.9 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 16 | 17.4 | 17.4 |
| Tenofovir Disoproxil Fumarate | 11 | 16.3 | 16.4 |
| Ledipasvir And Sofosbuvir | 5 | 12.6 | 12.6 |